N@N

Kendall Law Group Investigates Beckman Coulter, Inc. For Shareholders

_{//science-technology.news-articles.net/content/2 .. igates-beckman-coulter-inc-for-shareholders.html}
^{Published in Science and Technology on Tuesday, September 7th 2010 at 15:11 GMT by Market Wire}  

DALLAS--([ BUSINESS WIRE ])--[ Kendall Law Group ], a national securities firm led by a former federal judge with attorneys that include a former U.S. Attorney, is investigating Beckman Coulter, Inc. (NYSE: BEC) for shareholders. The investigation concerns potential breaches of fiduciary duties by the board of directors and other company executives in connection to the issuance of allegedly materially false and misleading statements regarding Beckmana™s business and financial results. Concerned Beckman shareholders should contact the Kendall Law Group at 877-744-3728 or by email at [ skendall@kendalllawgroup.com ].

On July 22, 2010, Beckman announced in its quarterly filing with the Securities and Exchange Commission that it had missed earnings estimates for the quarter and that it was reducing its guidance due in substantial part to troponin quality and compliance issues. Beckman's directors and officers failed to disclose the quality and compliance issues related to its troponin test kits, and Beckman stock reached a high of $71.20 per share on September 14, 2009. On July 23, 2010, Beckman's stock price fell $12.59 per share, a one-day decline of 21% on heavy volume trading.

Kendall Law Group has the credentials and experience to pursue any type of complex securities litigation in the nation. The firm helps shareholders exercise their power to protect their investments when companies break the law. If you are a Beckman shareholder, you are encouraged to contact the Kendall Law Group to learn more about your rights.